Aditxt stock.

Aditxt, Inc. analysts consensus, targets, ratings and recommendations | Nasdaq: ADTX | Nasdaq

Aditxt stock. Things To Know About Aditxt stock.

Apr 20, 2023 · RICHMOND, Va., April 20, 2023--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating ... Nov 30, 2023 · Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ... Aditxt, Inc. (ADTX) is a global innovation activation company that discovers, develops, and deploys technologies that monitor and modulate the immune system. The stock price, news, quote, history, and research reports of ADTX are available on Yahoo Finance. See the latest updates on its performance outlook, earnings date, dividend yield, and more.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.

RICHMOND, Va., August 31, 2023--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating ...Find the latest Aditxt, Inc. (ADTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Apr 15, 2023 · Aditxt's stock closed Friday at 87.49 cents per share. Pfizer's stock closed at $41.19. Amro Albanna, the co-founder, chairman and CEO of Richmond, Virginia-based Aditxt, contended that picking ...

What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...

Aditxt climbs 32% postmarket after completing 1-for-50 reverse stock split SA News Tue, Sep. 13, 2022 Aditxt stock surges 61% on positive preclinical toxicity study of its psoriasis drug candidateAditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ...Aditxt, Inc. ADTX shares are blasting higher Thursday despite a lack of company-specific news. Despite today's gains, the stock remains down by more than 20% over the last month. What To Know:Aditxt, Inc. ADTX shares rose 126.1% to $7.80 in pre-market trading. ... jumped 93% on Wednesday after the company effected a 1-for-10 reverse stock split for its Class A and Class B common stock.

Using data from Stockcharts, ADTX opened 2023 at a price of $44. Therefore, even with the upswing in shares today, Aditxt’s stock is down about 58%. In addition, investment data aggregator ...

The reverse stock split is primarily intended to bring the Company into compliance with Nasdaq’s minimum bid price requirement. Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on July 20, 2023, as amended. About Aditxt, Inc.

Nov 30, 2023 · Aditxt shares are down from a premarket high of $8.27 and are moving on very heavy trading volume. Aditxt, Inc. ADTX +31.7%. + Free Alerts. shares are blasting higher Thursday despite a lack of ... Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on July 20, 2023, as amended. ...On June 12, 2023, Amro Albanna, the Chief Executive Officer of Aditxt, Inc. (the "Company"), and Shahrokh Shabahang, the Chief Innovation Officer of the Company, loaned $200,000 and $100,000, respectively, to the Company. The loans were evidenced by an unsecured promissory note (the "Note").Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Aditxt, Inc., (NASDAQ: ADTX) (' Aditxt ' or the 'Company'), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announces the formation of a U.S.-based wholly- owned subsidiary, Pearsanta, Inc. ('Pearsanta'), to accelerate the growth of Aditxt's second program, AditxtScore, through future strategic revenue and ...17 thg 8, 2023 ... Aditxt®, Inc. (NASDAQ: ADTX) is a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system ...Market Average Movement. 6.0%. 10% most volatile stocks in US Market. 15.1%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: ADTX is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 59% a day. Volatility Over Time: ADTX's weekly volatility has increased from 67% to 131% over the past year.

Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on July 20, 2023, as amended ...Aditxt Inc ( ADTX) is up 130.00% today. ADTX has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on ADTX! ADTX stock closed at $3.50 and is up $4.55 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.Frequently Asked Questions for Aditxt, Inc. Shareholders Aditxt stock is traded on the Nasdaq Capital Market exchange under the ticker symbol ADTX, and its common stock CUSIP number is 007025505. Aditxt’s initial public offering (IPO) occurred on July 2, 2020. Vstock Transfer, LLC is Aditxt’s transfer agent. Vstock Transfer, LLC18 Lafayette Item 1.01 Entry into a Material Definitive Agreement. On March 17, 2023, Aditxt, Inc. (the "Company") entered into a consulting agreement (the "Consulting Agreement") with an independent consultant for a term of thirty days. Pursuant to the Consulting Agreement, the independent consultant agreed to provide the Company with …You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide brokerage services.Item 1.01. Entry into a Material Definitive Agreement. On December 20, 2022, Aditxt, Inc. (the "Company"), entered into an At The Market Offering Agreement (the "ATM Agreement") with H.C. Wainwright & Co., LLC as agent (the "Agent"), pursuant to which the Company may offer and sell, from time to time through the Agent, shares of the Company's common stock, par value $0.001 per share (the ...

Key Data. Open $3.5000. Day Range 3.3000 - 3.5765. 52 Week Range 3.2727 - 76.4000. Market Cap $1.55M. Shares Outstanding 441.85K. Public Float 189.2K. Beta 1.06. Rev. per Employee $12.29K.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) was the target of a significant growth in short interest during the month of November. As of November 15th, …28 thg 8, 2020 ... timely and fast moving immune monitoring technology coming to commercial market. #investors #stock #biotech #smallcapAditxt Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Stocks whose Next Earnings Date falls within the next 7 days are highlighted in red. Annual Dividend & Yield: The indicated annual dividend rate and yield, calculated from the latest dividend. The dividend rate is ...Nov 30, 2023 · Aditxt, Inc. (NASDAQ: ADTX) shares are blasting higher Thursday despite a lack of company-specific news. Despite today's gains, the stock remains down by more than 20% over the last month. Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on August 1, 2022, as amended. ...Certain Common Stock of Aditxt, Inc. are subject to a Lock-Up Agreement Ending on 24-JUL-2023. Jul. 23: CI Aditxt, Inc. announced that it has received $0.001 million in funding Jul. 10: CI Aditxt, Inc. announced that it has received $0.25 million in funding Jul. 02: CICertificate of Amendment to Certificate of Incorporation of Aditxt, Inc. (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on August 17, 2023) 08-17 - 2 views Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on August 18, 2023 08-17 - 2 views

Complete Aditxt Inc. stock information by Barron's. View real-time ADTX stock price and news, along with industry-best analysis.

RICHMOND, Va., April 24, 2023--Aditxt, Inc., (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating ...

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.4 days ago ... Thinking about buying stock in Aditxt Inc, Ampio Pharmaceuticals, TOP SHIPS, Mullen Automotive, or Oatly Group ? By InvestorsObserver, Aditxt ...Aditxt, Inc. : Industry and sector chart comparison Stock Aditxt, Inc. | ADTX | US0070256047 | Nasdaq.17 Nov 2023 ... Amro Albanna, CEO of Aditxt, Inc., was recently interviewed by Benzinga. Aditxt is an innovation platform commercializing promising ...Aditxt (NASDAQ: ADTX) stock is listed, by some tickers, as being up 35% this morning. Which, following a 37% price rise on Friday – because such rises are cumulative – means a near 100% appreciation in ADTX in only two trading days. Which is pretty good really. Other tickers are showing that Aditxt stock is in fact up 6,750% this …Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move ...What is Aditxt's consensus rating and price target? According to the issued ratings of 1 analysts in the last year, the consensus rating for Aditxt stock is Buy based on the current 1 buy rating for ADTX. The average twelve-month price prediction for Aditxt is $61.00 with a high price target of $61.00 and a low price target of $61.00.Certificate of Amendment to Certificate of Incorporation of Aditxt, Inc. (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on August 17, 2023) 08-17 - 2 views Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on August 18, 2023 08-17 - 2 viewsAditxt Inc. stock performance at a glance Check Aditxt Inc. ’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. ADTX Stock Performance

Aditxt stock drops 48% on $10M private placement msn.com - September 1 at 3:54 AM: Aditxt Announces $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules finance.yahoo.com - August 31 at 10:54 PM: What's Going On With Aditxt Stock Today benzinga.com - August 31 at 5:54 PM: marketbeat.com - August 31 at 3:57 …ADiTx Therapeutics Stock Earnings. The value each ADTX share was expected to gain vs. the value that each ADTX share actually gained. ADiTx Therapeutics ( ADTX) reported Q2 2023 earnings per share (EPS) of -$36.79, beating estimates of -$115.60 by 68.18%. In the same quarter last year, ADiTx Therapeutics 's earnings per share (EPS) was -$256.80 ...Get Aditxt Inc (ADTX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsInstagram:https://instagram. healthcare professional home loansbooks on options tradingtrustpilot stocksolar edge technologies Aditxt, Inc. (ADTX) is a global innovation activation company that discovers, develops, and deploys technologies that monitor and modulate the immune system. The stock price, news, quote, history, and research reports of ADTX are available on Yahoo Finance. See the latest updates on its performance outlook, earnings date, dividend yield, and more.On September 21, 2023, Aditxt Inc (ADTX) stock experienced a decline in its price. The data reveals that one analyst has provided a 12-month price forecast for ADTX stock. The median target price is $3.70, with both the high and low estimates also being $3.70. However, the median estimate represents a significant decrease of 79.11% from the ... best microcap stocksprime stock price The latest Aditxt stock prices, stock quotes, news, and ADTX history to help you invest and trade smarter.Aditxt (NASDAQ: ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. No new press releases or filings with the Securities and Exchange Commission (SEC ... gold double eagle value Aditxt Inc (ADTX) stock is trading at $14.75 as of 10:47 AM on Thursday, Sep 28, a rise of $1.71, or 13.15% from the previous closing price of $13.04. The stock has traded between $13.33 and $24.00 so far today. Volume today is low. So far 308,003 shares have traded compared to average volume of 419,078 shares. More About Aditxt Incmsn.com - September 7 at 4:44 AM. Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules. finance.yahoo.com - September 6 at 6:43 PM. marketbeat.com - September 6 at 9:42 AM. Aditxt (NASDAQ:ADTX) Plummets on $10M Private Placement. msn.com - September 1 at 11:26 PM.Aditxt, Inc. (NASDAQ: ADTX) shares are blasting higher Thursday despite a lack of company-specific news. Despite today's gains, the stock remains down by more than 20% over the last month.